Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.
Oncotarget
Spans, Lien L; Van den Broeck, Thomas T; Smeets, Elien E; Prekovic, Stefan S; Thienpont, Bernard B; Lambrechts, Diether D; Karnes, R Jeffrey RJ; Erho, Nicholas N; Alshalalfa, Mohammed M; Davicioni, Elai E; Helsen, Christine C; Gevaert, Thomas T; Tosco, Lorenzo L; Haustermans, Karin K; Lerut, Evelyne E; Joniau, Steven S; Claessens, Frank F